Elevated levels of soluble protein PD-L1 were associated with poorer survival with ICI treatment in NSCLC and a meta-analysis of eight studies with over 1000 patients across a variety of solid tumors [1,2]. Here, CD274 is linked to non-small cell lung carcinoma.